Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
UBER Uber Technologies Inc
LMT Lockheed Martin Corp
SHLX Shell Midstream Partners LP
SEDG Solaredge Technologies Inc
LUNA Luna Innovations Inc
PAAS Pan American Silver Corp
FSD First Trust High Inc Long/Short Fund
GDV Gabelli Dividend & Income Trust
MNSB MainStreet Bancshares Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Based in Switzerland
Company profile

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$80.70
Day's Change
-1.21 (-1.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
81.23
Day's Low
80.53
Volume
(Below Average)
Volume:
1,730,333

10-day average volume:
2,011,874
1,730,333

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.